Clinical Trial Update: 12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating NFX-179 Gel for epidermal nevus and nevus sebaceus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermal Nevus
• Nevus Sebaceus

Drugs mentioned

• NFX-179 Gel (NFX-179)

Snippet

Sponsor: Albert Chiou | Conditions: Epidermal Nevi, Nevus Sebaceus | Phase 2 | Status: WITHDRAWN